A meta-analysis of 13 studies showed that patients who underwent sentinel node biopsy had a significantly reduced risk of death from melanoma. In addition, an analysis of nine studies showed that the ...

Limited data are available on survival outcomes after sentinel-lymph-node biopsy alone as compared with lymphadenectomy in cervical cancer. In this multicenter, randomized, noninferiority trial, we ...

Please provide your email address to receive an email when new articles are posted on . Sentinel lymph node biopsy (SLNB) is a low-risk procedure that can reduce the need for complete lymph node ...

Effect of circulating tumor cells (CTCs) on overall survival in metastatic medullary thyroid cancer (metMTC). Accurate detection of circulating tumor cells (CTCs) in patients with metastatic papillary ...

Purpose Complicated gastric lymphatic drainage potentially undermines the utility of sentinel node (SN) biopsy in patients with gastric cancer. Encouraged by several favorable single-institution ...

Please provide your email address to receive an email when new articles are posted on . Sentinel lymph node biopsy was effective as a prognostic and staging tool in stage IIB/C melanoma, according to ...

A systematic review and meta-analysis demonstrates that human papillomavirus positivity in cervical cancer is associated with better overall, cancer-specific, and disease-free survival. HPV Types in ...

Surgery is usually the main treatment for most types and stages of melanoma. If your tumor is in an early stage and removed using a melanoma surgical treatment, you may not need any other treatment.

DUBLIN, Ohio--(BUSINESS WIRE)--Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) (“Navidea” or the “Company”), a company focused on the development of precision immunodiagnostic agents and ...

Omitting sentinel lymph node biopsy (SLNB) in patients with early-stage breast cancer undergoing breast-conserving surgery may not increase the risk for recurrence over 5 years, according to findings ...

Skipping sentinel lymph node biopsy (SLNB) in patients with clinically node-negative, hormonal receptor (HR)-positive, HER2-negative early-stage breast cancer did not compromise regional control or ...